ITGAX and prostate cancer: Accumulation of lineage- (lin-) HLA DR+CD11c-CD123- blood cells (non DC) coincides with a reduction in the CD11c+ DC and/or CD123+ DCs in subjects with breast cancer, prostate cancer, and malignant glioma [32].